Online-Trading Portfolio-Tracker Research Back-Office MF-Tracker
BSE Prices delayed by 5 minutes... << Prices as on May 06, 2024 >>   ABB 6942.3 [ 3.64 ]ACC 2490.75 [ -1.71 ]AMBUJA CEM 605.95 [ -2.62 ]ASIAN PAINTS 2932.2 [ 0.16 ]AXIS BANK 1144.15 [ 0.27 ]BAJAJ AUTO 9048.65 [ -0.55 ]BANKOFBARODA 265.75 [ -3.71 ]BHARTI AIRTE 1283.35 [ 0.52 ]BHEL 289 [ -5.28 ]BPCL 610.05 [ -3.14 ]BRITANIAINDS 5061.6 [ 6.67 ]CIPLA 1423.4 [ -0.09 ]COAL INDIA 460.45 [ -3.02 ]COLGATEPALMO 2859.65 [ 2.36 ]DABUR INDIA 530.85 [ -0.08 ]DLF 887.05 [ 1.02 ]DRREDDYSLAB 6300.8 [ -0.77 ]GAIL 197.7 [ -2.99 ]GRASIM INDS 2452.6 [ -1.20 ]HCLTECHNOLOG 1359.75 [ 0.89 ]HDFC 2729.95 [ -0.62 ]HDFC BANK 1522.8 [ 0.27 ]HEROMOTOCORP 4509.3 [ -0.83 ]HIND.UNILEV 2255.35 [ 1.80 ]HINDALCO 638.5 [ -1.32 ]ICICI BANK 1148.8 [ 0.60 ]IDFC 118.1 [ -1.09 ]INDIANHOTELS 570.95 [ 0.01 ]INDUSINDBANK 1498.35 [ 1.06 ]INFOSYS 1425.8 [ 0.66 ]ITC LTD 434.6 [ -0.38 ]JINDALSTLPOW 936.6 [ 0.54 ]KOTAK BANK 1624.75 [ 5.01 ]L&T 3462.1 [ -1.06 ]LUPIN 1679.75 [ 1.48 ]MAH&MAH 2224.7 [ 1.45 ]MARUTI SUZUK 12433.15 [ -0.46 ]MTNL 36.62 [ -3.76 ]NESTLE 2458 [ 0.10 ]NIIT 103.35 [ -1.05 ]NMDC 269.25 [ 0.06 ]NTPC 356.65 [ -2.31 ]ONGC 282 [ -1.40 ]PNB 127.1 [ -6.41 ]POWER GRID 306.9 [ -1.22 ]RIL 2839 [ -1.03 ]SBI 807.75 [ -2.86 ]SESA GOA 410.6 [ -1.10 ]SHIPPINGCORP 215.35 [ -2.78 ]SUNPHRMINDS 1529.7 [ 1.41 ]TATA CHEM 1082.85 [ -0.72 ]TATA GLOBAL 1098.3 [ 0.40 ]TATA MOTORS 1015.8 [ 0.20 ]TATA STEEL 167.6 [ 0.69 ]TATAPOWERCOM 446.15 [ -1.86 ]TCS 3920.7 [ 2.12 ]TECH MAHINDR 1262.3 [ 1.01 ]ULTRATECHCEM 9778.15 [ -0.39 ]UNITED SPIRI 1229.85 [ 1.79 ]WIPRO 458.25 [ 0.31 ]ZEETELEFILMS 136.65 [ -4.47 ] BSE NSE
You can view full text of the latest Auditor's Report for the company.

BSE: 543245ISIN: INE068V01023INDUSTRY: Pharmaceuticals

BSE   ` 1705.15   Open: 1694.95   Today's Range 1666.95
1709.90
+21.35 (+ 1.25 %) Prev Close: 1683.80 52 Week Range 861.50
2195.75
Year End :2023-03 

To the Members of Gland Pharma Limited

Report on the Audit of the Standalone Ind AS Financial Statements

Opinion

We have audited the accompanying standalone Ind AS financial statements of Gland Pharma Limited ("the Company”), which comprise the Balance sheet as at March 31, 2023 the Statement of Profit and Loss, including the statement of Other Comprehensive Income, the Cash Flow Statement and the Statement of Changes in Equity for the year then ended, and notes to the standalone Ind AS financial statements, including a summary of significant accounting policies and other explanatory information.

In our opinion and to the best of our information and according to the explanations given to us the aforesaid standalone Ind AS financial statements give the information required by the Companies Act, 2013, as amended ("the Act”) in the manner so required and give a true and fair view in conformity with the accounting principles generally accepted in India, of the state of affairs of the Company as at March 31, 2023, its profit including other comprehensive income, its cash flows and the changes in equity for the year ended on that date.

Basis for Opinion

We conducted our audit of the standalone Ind AS financial statements in accordance with the Standards on Auditing (SAs), as specified under section 143(10) of the Act. Our responsibilities under those Standards are further described in the 'Auditor's Responsibilities for the Audit of the Standalone Ind AS Financial Statements' section of our report. We are independent of the Company in accordance with the 'Code of Ethics' issued by

the Institute of Chartered Accountants of India together with the ethical requirements that are relevant to our audit of the financial statements under the provisions of the Act and the Rules thereunder, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the Code of Ethics. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion on the standalone Ind AS financial statements.

Key audit matters

How our audit addressed the key audit matter

Revenue from sale of products and services

Refer to Note 2.1 (e) of the summary of significant

Our audit procedures included the following:

accounting policies to the standalone Ind AS financial statements.

• We evaluated the Company's accounting policies related

to

revenue recognition and assessed its compliance in terms

of

Revenue is recognised when the entity has transferred

Ind-AS 115 'Revenue from contracts with customers';

the control for the promised goods or on completion of performance obligation. The Company has a large number of customers operating in various geographies and sale contracts with customers have different terms

• We performed a walkthrough, evaluated the design and tested the operating effectiveness of controls related to the revenue recognition process;

relating to the recognition of revenue.

Key audit matters

How our audit addressed the key audit matter

Terms of sales arrangement, including the timing

of

• For revenue from sale of products, we selected samples

transfer of control, Inco terms and identification

of

(including year-end testing of cut-off transactions) and tested the

Performance obligations in case of service contracts

underlying documents, including customer contracts, invoices

require significant judgement in determining revenue.

and shipping documents to assess and analyse the timing of

We identified the recognition of revenue from sale of products and services as a key audit matter as revenue is a key performance indicator and there could be a risk that revenue is recognised in the incorrect period.

recognition of revenue and contractual terms; Performed trend analysis over revenue as compared to previous periods.

• For revenue from sale of services, we selected samples and tested underlying documents and read, analysed the distinct performance obligations in these contracts.

• We assessed the disclosures in accordance with Ind AS 115

"Revenue from contracts with customers”

Key Audit Matters

Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the standalone Ind AS financial statements for the financial year ended March 31, 2023. These matters were addressed in the context of our audit of the standalone Ind AS financial statements as a whole, and in forming our opinion thereon and we do not provide a separate opinion on these matters. For each matter below, our description of how our audit addressed the matter is provided in that context.

We have determined the matters described below to be the key audit matters to be communicated in our report. We have fulfilled the responsibilities described in the Auditor's responsibilities for the audit of the standalone Ind AS financial statements section of our report, including in relation to these matters. Accordingly, our audit included the performance of procedures designed to respond to our assessment of the risks of material misstatement of the standalone Ind AS financial statements. The results of our audit procedures, including the procedures performed to address the matters below, provide the basis for our audit opinion on the accompanying standalone Ind AS financial statements.

Other Information

The Company's Board of Directors is responsible for the other information. The other information comprises the information included in the Board of Directors' report, but does not include the standalone Ind AS financial statements and our auditor's report thereon.

Our opinion on the standalone Ind AS financial statements does not cover the other information and we do not express any form of assurance conclusion thereon.

In connection with our audit of the standalone Ind AS financial statements, our responsibility is to read the other information and, in doing so, consider whether such other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Responsibilities of Management for the Standalone Ind AS Financial Statements

The Company's Board of Directors is responsible for the matters stated in section 134(5) of the Act with respect to the preparation of these standalone Ind AS financial statements that give a true and fair view of the financial position, financial performance including other comprehensive income, cash flows and changes in equity of the Company in accordance with the accounting principles generally accepted in India, including the Indian Accounting Standards (Ind AS) specified under section 133 of the Act read with the Companies (Indian Accounting Standards) Rules, 2015, as amended. This responsibility also includes maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding of the assets of the Company and for preventing and detecting frauds and other irregularities; selection and application of appropriate accounting policies; making judgments and estimates that are reasonable and prudent; and the design, implementation and maintenance

of adequate internal financial controls, that were operating effectively for ensuring the accuracy and completeness of the accounting records, relevant to the preparation and presentation of the standalone Ind AS financial statements that give a true and fair view and are free from material misstatement, whether due to fraud or error.

In preparing the standalone Ind AS financial statements, management is responsible for assessing the Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless management either intends to liquidate the Company or to cease operations, or has no realistic alternative but to do so.

Those Board of Directors are also responsible for overseeing the Company's financial reporting process.

Auditor's Responsibilities for the Audit of the Standalone Ind AS Financial Statements

Our objectives are to obtain reasonable assurance about whether the standalone Ind AS financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with SAs will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these standalone Ind AS financial statements.

As part of an audit in accordance with SAs, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:

• Identify and assess the risks of material misstatement of the standalone Ind AS financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is

sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

• Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances. Under section 143(3) (i) of the Act, we are also responsible for expressing our opinion on whether the Company has adequate internal financial controls with reference to financial statements in place and the operating effectiveness of such controls.

• Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by management.

• Conclude on the appropriateness of management's use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Company's ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor's report to the related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor's report. However, future events or conditions may cause the Company to cease to continue as a going concern.

• Evaluate the overall presentation, structure and content of the standalone Ind AS financial statements, including the disclosures, and whether the standalone Ind AS financial statements represent the underlying transactions and events in a manner that achieves fair presentation.

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.

From the matters communicated with those charged with governance, we determine those matters that were of most significance in the audit of the standalone Ind AS financial statements for the financial year ended March 31, 2023 and are therefore the key audit matters. We describe these matters in our auditor's report unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we determine that a matter should

not be communicated in our report because the adverse consequences of doing so would reasonably be expected to outweigh the public interest benefits of such communication.

Report on Other Legal and Regulatory Requirements

1. As required by the Companies (Auditor's Report) Order,

2020 ("the Order”), issued by the Central Government of

India in terms of sub-section (11) of section 143 of the Act,

we give in the "Annexure 1” a statement on the matters

specified in paragraphs 3 and 4 of the Order.

2. As required by Section 143(3) of the Act, we report that:

(a) We have sought and obtained all the information and explanations which to the best of our knowledge and belief were necessary for the purposes of our audit;

(b) In our opinion, proper books of account as required by law have been kept by the Company so far as it appears from our examination of those books;

(c) The Balance Sheet, the Statement of Profit and Loss including the Statement of Other Comprehensive Income, the Cash Flow Statement and Statement of Changes in Equity dealt with by this Report are in agreement with the books of account;

(d) In our opinion, the aforesaid standalone Ind AS financial statements comply with the Accounting Standards specified under Section 133 of the Act, read with Companies (Indian Accounting Standards) Rules, 2015, as amended;

(e) On the basis of the written representations received from the directors as on March 31, 2023 taken on record by the Board of Directors, none of the directors is disqualified as on March 31, 2023 from being appointed as a director in terms of Section 164 (2) of the Act;

(f) With respect to the adequacy of the internal financial controls with reference to these standalone Ind AS financial statements and the operating effectiveness of such controls, refer to our separate Report in "Annexure 2” to this report;

(g) In our opinion, the managerial remuneration for the year ended March 31, 2023 has been paid / provided by the Company to its directors in accordance with the provisions of section 197 read with Schedule V to the Act;

(h) With respect to the other matters to be included in the Auditor's Report in accordance with Rule 11 of the Companies (Audit and Auditors) Rules, 2014, as amended in our opinion and to the best of our information and according to the explanations given to us:

i. The Company has disclosed the impact of pending litigations on its financial position in its

standalone Ind AS financial statements - Refer Note 46 (b) to the standalone Ind AS financial statements;

ii. The Company did not have any long-term contracts including derivative contracts for which there were any material foreseeable losses;

iii. There were no amounts which were required to be transferred to the Investor Education and Protection Fund by the Company.

iv. a) The management has represented that, to the

best of its knowledge and belief, no funds have been advanced or loaned or invested (either from borrowed funds or share premium or any other sources or kind of funds) by the Company to or in any other persons or entities, including foreign entities ("Intermediaries”), with the understanding, whether recorded in writing or otherwise, that the Intermediary shall, whether, directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the Company ("Ultimate Beneficiaries”) or provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries;

b) The management has represented that, to the best of its knowledge and belief, no funds have been received by the Company from any persons or entities, including foreign entities ("Funding Parties”), with the understanding, whether recorded in writing or otherwise, that the Company shall, whether, directly or indirectly, lend or invest

in other persons or entities identified in any manner whatsoever by or on behalf of the Funding Party ("Ultimate Beneficiaries”) or provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries; and

c) Based on such audit procedures performed that have been considered reasonable and appropriate in the circumstances, nothing has come to our notice that has caused us to believe that the representations under sub-clause (a) and (b) contain any material misstatement.

v. No dividend has been declared or paid during the year by the company; and

vi. As proviso to Rule 3(1) of the Companies (Accounts) Rules, 2014 is applicable for the Company only w.e.f. April 1, 2023, reporting under this clause is not applicable.

For S.R. Batliboi & Associates LLP

Chartered Accountants

ICAI Firm Registration Number: 101049W/E300004

per Vineet Kedia

Partner

Membership Number: 212230

UDIN: 23212230BGSSET2533

Place of Signature: Hyderabad

Date: May 18, 2023